Athersys to Host Second Quarter Financial Results Call
Athersys, Inc. (Nasdaq: ATHX) is set to release its second quarter 2021 financial results on August 9, 2021, at 4:00 PM Eastern Time. Following the results, a conference call will be held at 4:30 PM to discuss the outcomes. Shareholders can join via a webcast or by phone after registering. A replay will be available shortly after the call, providing further insights for investors.
- None.
- None.
Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2021 financial results at approximately 4:00 PM Eastern Time on Monday, August 9, 2021, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.
Members of the management team will host the call as follows:
Date |
August 9, 2021 |
Time |
4:30 p.m. (Eastern Time) |
Live webcast registration |
|
Phone registration |
We encourage shareholders to listen using the webcast link above. If you would like to dial in using the phone to ask a question, please register for the conference call ahead of time using the call registration link above. Once registered, you will receive an email containing the toll-free number, a direct entry passcode and a registrant ID.
A replay of the event will be available on the webcast link at www.athersys.com under the investors' section approximately two hours after the call has ended. Shareholders may also call in for on-demand listening approximately three hours after the completion of the call until 11:59 PM Eastern Time on August 16, 2021, by dialing (800) 585-8367 or (416) 621-4642 and entering the conference code 5972392.
About Athersys
Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005816/en/
FAQ
When will Athersys announce its Q2 2021 financial results?
What time is the Athersys Q2 2021 conference call?
How can I listen to the Athersys conference call?
Will a replay of the Athersys conference call be available?
